Shree Hari Chemicals Export approved a preferential issue of 22,85,000 convertible warrants aggregating to ₹40.24 crore on August 25, 2026. The board meeting authorized the issuance at a price of ₹176.10 per warrant, subject to shareholder approval.

The warrants are allotted to four promoter entities: Shri Nihit Agarwal, Smt Priyamvada Agarwal, Smt Avanticka Agarwal, and Smt Smradhi Agarwal. Each warrant is convertible into one equity share of face value ₹10 at a premium of ₹166.10 per share.

Issue Structure

The company outlined the payment terms and conversion timeline for the instruments. Investors must pay 25% of the issue price at the time of subscription and allotment. The remaining 75% is due on or before the exercise of the conversion right.

Conversion must occur in one or more tranches within 18 months from the date of allotment. The company will intimate the stock exchange upon conversion or lapse of the instrument tenure.

Promoter Shareholding Impact

The table below details the proposed allotment and the resulting post-conversion shareholding pattern for the promoters.

The post-conversion percentages reflect the expected ownership assuming full conversion of all issued warrants within the stipulated period.

Shree Hari Chemicals Export Limited's Board of Directors approved the audited standalone and consolidated financial statements for the year ended March 31, 2026. The results were reviewed by the Audit Committee and received an unmodified opinion from auditors Kailash Chand Jain & Co.

Standalone Financial Performance

On a standalone basis, the company recorded revenue from operations of Rs. 18,450.48 lakhs for FY26, compared to Rs. 14,119.58 lakhs in FY25. Total income stood at Rs. 18,756.27 lakhs. Net profit for the year declined to Rs. 422.22 lakhs from Rs. 512.40 lakhs in the previous year. Total comprehensive income for FY26 was Rs. 421.01 lakhs.

Consolidated Financial Performance

On a consolidated basis, total income for FY26 was Rs. 18,763.84 lakhs (FY25: Rs. 14,206.70 lakhs). Consolidated net profit was Rs. 411.81 lakhs versus Rs. 509.75 lakhs in FY25. Total comprehensive income attributable to owners was Rs. 410.61 lakhs.

Balance Sheet and Cash Flow

The standalone balance sheet as of March 31, 2026, reflects total assets of Rs. 10,242.83 lakhs, up from Rs. 8,662.52 lakhs. Equity share capital stood at Rs. 553.79 lakhs. The standalone cash flow statement shows cash generated from operating activities of Rs. 1,105.64 lakhs, compared to an outflow of Rs. (147.26) lakhs in the prior year. The closing cash balance was Rs. 55.37 lakhs.

Regulatory Disclosures

Pursuant to Regulation 32(1), the company confirmed no deviations in the utilization of proceeds from its Preferential Issue, which raised Rs. 14,74,59,820. Regarding the SEBI Circular on Large Corporates, outstanding qualified borrowings at the end of FY26 were Rs. 28.38 crores, with no incremental borrowing or debt securities issued during the year.